Rocky Mountain Cancer Centers,2030 Mountain View Ave Ste 210 is a clinical research site located in Longmont, Colorado, United States 80124.
Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.
Rocky Mountain Cancer Centers,2030 Mountain View Ave Ste 210 has participated in 2 clinical trials with 2 currently active.
Therapeutic areas: Triple Negative Breast Cancer, PD-L1 Negative, PD-L1 Positive.
Sponsors: Gilead Sciences.
Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Rocky Mountain Cancer Centers,2030 Mountain View Ave Ste 210 has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Rocky Mountain Cancer Centers,2030 Mountain View Ave Ste 210 has 2 clinical trials on record, with 2 currently active. Their work covers Triple Negative Breast Cancer, PD-L1 Negative, PD-L1 Positive.
Rocky Mountain Cancer Centers,2030 Mountain View Ave Ste 210 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.